HI
REGN icon

Harbour Investments’s Regeneron Pharmaceuticals REGN Stock Holding History

Harbour Investments’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$495K Buy
640
+429
+203% +$328K 0.01% 1065
2025
Q4 		$163K Sell
211
-14
-6% -$9.51K ﹤0.01% 1386
2025
Q3 		$127K Sell
225
-129
-36% -$72.9K ﹤0.01% 1472
2025
Q2 		$186K Sell
354
-49
-12% -$27.3K ﹤0.01% 1205
2025
Q1 		$256K Sell
403
-32
-7% -$22K 0.01% 992
2024
Q4 		$310K Sell
435
-13
-3% -$10.9K 0.01% 858
2024
Q3 		$471K Sell
448
-13
-3% -$14.5K 0.01% 683
2024
Q2 		$485K Sell
461
-92
-17% -$89.2K 0.02% 610
2024
Q1 		$532K Buy
553
+162
+41% +$154K 0.02% 572
2023
Q4 		$343K Buy
391
+7
+2% +$5.76K 0.01% 669
2023
Q3 		$316K Sell
384
-72
-16% -$56.6K 0.02% 633
2023
Q2 		$328K Buy
456
+63
+16% +$48.6K 0.02% 630
2023
Q1 		$323K Sell
393
-3
-0.8% -$2.26K 0.02% 601
2022
Q4 		$286K Buy
396
+7
+2% +$5.17K 0.02% 614
2022
Q3 		$230K Hold
389
– – 0.02% 638
2022
Q2 		$230K Buy
+389
New +$253K 0.02% 638
2021
Q4 		$256K Buy
405
+46
+13% +$28.3K 0.02% 628
2021
Q3 		$217K Sell
359
-5
-1% -$3.1K 0.01% 984
2021
Q2 		$203K Sell
364
-54
-13% -$27.4K 0.01% 1036
2021
Q1 		$198K Buy
+418
New +$204K 0.01% 966

Other funds holding REGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Harbour Investments's REGN Position: Q1 2026 in Review

Harbour Investments increased its Regeneron Pharmaceuticals (REGN) stake by 203% in Q1 2026, buying an estimated $328K and bringing the position to 640 shares worth $495K. The position accounts for 0.01% of the portfolio, ranked #1065.

Harbour Investments first reported a position in REGN in Q1 2021 and has held it in 20 quarters since. The position peaked at $532K in Q1 2024. 1,392 funds tracked by Wall St. Rank hold REGN as of Q1 2026.

  • Harbour Investments held 640 shares of Regeneron Pharmaceuticals worth $495K as of Q1 2026.
  • Harbour Investments bought 429 Regeneron Pharmaceuticals shares in Q1 2026, an estimated $328K.
  • Regeneron Pharmaceuticals made up 0.01% of Harbour Investments's portfolio in Q1 2026, its #1065 holding.
  • Harbour Investments first reported a position in Regeneron Pharmaceuticals in Q1 2021 and has held it in 20 quarters since.
  • Harbour Investments's Regeneron Pharmaceuticals position peaked at $532K in Q1 2024.
  • 1,392 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.

Based on Harbour Investments's 13F filing for Q1 2026, filed 15 May 2026.